AI Analytics InSyBio Suite positions as a robust AI-powered analytics platform for biomarker discovery and integrated omics analysis, appealing to biotech labs, academic researchers, and CROs seeking faster, cost-efficient data analyses and improved predictive modeling.

Personalization Market Capitalize on the expanded personalization offering for nutrition and nutraceuticals by selling the InSyBio Personalization Test and related services to product developers who want to pre-validate customer outcomes before purchase.

Credible Partnerships Leverage recent partnerships and awards to shorten sales cycles by proposing joint demos with Syndesis Health and JSSresearch, and by citing the CPHI Best Start-Up Initiative award to build trust with pharma and biotech buyers.

Flexible Licensing Provide accessible entry points with installation-free InSyBio Suite access, including free trial licenses and 3- or 12-month plans, to accelerate adoption among small to mid-size labs and research teams.

RWE and Omics Emphasize capabilities to integrate multi-omics data with real-world evidence to support clinical decision making and personalized therapies, appealing to pharma, healthcare providers, and research institutions pursuing RWE-driven outcomes.